Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 44.60B | 44.69B | 45.35B | 42.89B | 28.51B | 26.01B |
Gross Profit | 7.83B | 7.77B | 7.50B | 7.15B | 4.60B | 3.89B |
EBITDA | 5.79B | 6.02B | 5.86B | 5.00B | 3.09B | 2.51B |
Net Income | 1.10B | 1.10B | 937.00M | 1.08B | 404.30M | 88.80M |
Balance Sheet | ||||||
Total Assets | 68.97B | 72.96B | 72.57B | 73.30B | 53.08B | 45.36B |
Cash, Cash Equivalents and Short-Term Investments | 9.46B | 11.76B | 10.79B | 10.86B | 11.96B | 6.84B |
Total Debt | 30.08B | 19.96B | 31.98B | 21.88B | 12.97B | 12.77B |
Total Liabilities | 56.25B | 57.65B | 57.86B | 58.44B | 40.31B | 37.05B |
Stockholders Equity | 10.49B | 12.91B | 8.68B | 3.57B | 11.52B | 7.22B |
Cash Flow | ||||||
Free Cash Flow | 1.67B | 5.04B | 1.40B | 1.36B | 1.42B | 1.12B |
Operating Cash Flow | 4.61B | 5.04B | 5.00B | 4.15B | 3.15B | 2.73B |
Investing Cash Flow | -2.54B | -2.12B | -2.12B | 4.52B | -850.60M | -6.14B |
Financing Cash Flow | -1.82B | -1.86B | -2.51B | -10.17B | 2.29B | 3.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | €20.96B | 19.29 | 15.69% | 4.89% | -0.31% | 1.28% | |
63 Neutral | 595.95M | 13.36 | 9.76% | 1.57% | 14.77% | 33.13% | |
62 Neutral | 822.49M | 7.69 | 7.26% | 2.52% | 1.10% | 10.21% | |
57 Neutral | 50.64M | 50.49 | 1.44% | ― | -0.37% | -76.92% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |